ARIAD Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals

ARIA 23.99

0.0%

Feb 17 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scott_jiminez who wrote (863)	1/16/2000 9:10:00 PM
From: Pseudo Biologist	Read Replies (1) of 4474

1. If you want to call ARIA genomics or bioinformatics, fine with me. Allow me to disagree. End of discussion as far as I am concerned. 2. I presented a possible explanation or even account of why the stock has behaved the way it did. If that struck you as pretentious, so be it. I wonder why your explanation is not pretentious -g-. Again, fine with me. 3. Complexities of ARGENT. I am referring to clinical development. Again, if one wants to believe that developing this multi-component scheme is as "easy and straightforward" as any other old drug or even direct gene therapy, fine with me. Allow me to disagree. As for calling Schreiber or Crabtree, I am not sure what the point would be when I can read the papers, even had the luck of listening to Schreiber himself explain the whole thing in a Protein Society meeting a few years back. Good afternoon and good luck with your ARIA investment. I will continue to hold a portion of my shares bought at 1 1/16(sorry I could not hit the ~ 1/2 bottom, oh well), waiting for that big pharma deal and further clinical progress. PB (resident hair splitter, move over Dr. Harmon -g-)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next